市場調查報告書
商品編碼
1451733
2024-2032 年按產品、疾病、給藥途徑、配銷通路和地區分類的豬隻保健品市場報告Swine Healthcare Market Report by Product, Disease, Route of Administration, Distribution Channel, and Region 2024-2032 |
2023年,全球豬隻保健市場規模達到30億美元。展望未來, IMARC Group預計到2032年市場規模將達到53億美元,2024-2032年複合年成長率(CAGR)為6.48%。對生豬產品的日益依賴、商業生豬養殖和出口活動的大幅增加以及對豬肉傳播疾病的認知不斷增強,是推動市場發展的一些關鍵因素。
豬保健是指一系列旨在減輕豬疾病期間不適的產品、治療程序和診斷試劑盒。它的重點是治療不孕症和先天性異常等與豬相關的常見疾病,以及開發預防此類疾病的療法。協調的全球疾病監測、最大限度地減少未來威脅影響的有針對性的研究投資以及資料分析是豬隻醫療保健管理的一部分。除此之外,它還包括預防病毒和細菌,同時透過適當的定時疫苗接種和負責任的抗生素使用來增強牛群疾病免疫力。除了為生豬提供健康服務外,生豬醫療保健系統還透過豬舍設計、豬隻運輸、疫苗接種方案、豬群健康監測、疾病監測和適合具體情況的診斷測試,促進最大限度地降低疾病風險。
群眾對生豬產品的依賴程度不斷增加是推動市場成長的關鍵因素之一。這可以歸因於全球商業養豬和出口活動的大幅成長。同時,包括豬流感、沙門氏菌、豬肺炎支原體和豬瘟(CSF)在內的多種疾病的盛行率不斷上升,正在推動市場的發展。此外,人們對豬肉傳播疾病的認知不斷增強,導致豬隻保健品的使用量增加。此外,政府機構為維護豬隻的健康所採取的有利措施也推動了市場的成長。不斷成長的豬肉消費群體推動了對健康生豬牲畜的需求,這進一步為市場提供了動力。除此之外,廣泛的研發(R&D)活動,尤其是開發預防豬流感和豬瘟的疫苗以及減少豬病對人類的影響,也為市場做出了貢獻。此外,獸醫醫院擴大採用診斷影像,導致對配件和診斷設備的需求不斷增加,這也為市場做出了貢獻。創造積極市場前景的其他一些因素包括疫苗、抗生素和手術治療的採用率不斷提高,以提高牲畜產量,食源性疾病發病率顯著上升,全球化的迅速發展,對有機豬肉的需求不斷增加,以及相當大的食品和飲料 (F&B) 行業的成長。
The global swine healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.48% during 2024-2032. The increasing dependency on swine products, a considerable rise in commercial swine farming and export activities, and the growing awareness regarding pork-transmitted diseases represent some of the key factors driving the market.
Swine healthcare refers to a broad category of products, treatment procedures, and diagnostic kits that aim to alleviate discomfort during swine diseases. It focuses on treatments for common pig-related disorders like infertility and congenital anomalies as well as the development of therapeutics to prevent such diseases. Coordinated global disease monitoring, targeted research investments that minimize future threat effects, and data analysis are part of swine healthcare management. Along with this, it involves the prevention of viruses and bacteria while enhancing herd disease immunity with appropriately timed vaccinations and responsible antibiotic use. In addition to providing health services to pigs, the swine healthcare system promotes minimizing disease risks through barn design, pig movement, vaccination protocols, herd health monitoring, disease surveillance, and diagnostic tests that are appropriate for the situation.
The increasing dependency on swine products among the masses is one of the key factors driving the growth of the market. This can be attributed to a considerable rise in commercial swine farming and export activities across the globe. In line with this, the rising prevalence of numerous diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF), is fueling the market. Moreover, the augmenting awareness regarding pork-transmitted diseases is resulting in a higher uptake of swine healthcare products. Also, favorable initiatives taken by government bodies toward swine health maintenance are fueling the market growth. The continuously growing pork-eating population is propelling the demand for healthy swine livestock, which is further providing an impetus to the market. Besides this, extensive research and development (R&D) activities with an enhanced focus on the development of vaccines to prevent swine flu and swine fever and reduce the effects of swine diseases on humans are contributing to the market. Additionally, the augmenting incorporation of diagnostic imaging in veterinary hospitals leading to an escalating demand for accessories and diagnostic equipment is contributing to the market. Some of the other factors creating a positive market outlook include the growing adoption rates of vaccines, antibiotics, and surgical treatments for increasing livestock production, a significant rise in the rates of foodborne diseases, rapid globalization, the accelerating demand for organic pork, and considerable growth in the food and beverage (F&B) industry.
IMARC Group provides an analysis of the key trends in each segment of the global swine healthcare market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, disease, route of administration and distribution channel.
Diagnostic Tests
Enzyme Linked Immuno-Sorbent Assay (ELISA)
Rapid Immuno Migration (RIM)
Agar Gel Immuno-Diffusion (AGID)
Polymerase Chain Reaction (PCR)
Diagnostic Imaging
Others
Therapeutics
Vaccines
Parasiticides
Anti-infectives
Feed Additives
Others
The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.
Exudative Dermatitis
Coccidiosis
Respiratory Diseases
Swine Dysentery
Porcine Parvovirus
Others
A detailed breakup and analysis of the swine healthcare market based on the disease has also been provided in the report. This includes exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and others. According to the report, respiratory diseases accounted for the largest market share.
Injectable
Oral
A detailed breakup and analysis of the swine healthcare market based on the route of administration has also been provided in the report. This includes injectable and oral.
Veterinary Hospitals
Retail Pharmacy
Online Pharmacy
A detailed breakup and analysis of the swine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals, retail pharmacy and online pharmacy.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for swine healthcare. Some of the factors driving the North America swine healthcare market included the growing consumption of pork, improving animal healthcare infrastructure, the growing consciousness regarding pork-transmitted diseases, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global swine healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Elanco, IDEXX Laboratories Inc., Innovative Diagnostic, Merck & Co. Inc., Phibro Animal Health Corporation, Vetoquinol, Virbac Corporation, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report